# Methodology | This GLP

Every score on This GLP is computed from a published rubric — evidence, price transparency, real monthly cost, formats, and prescribing process. Scores never move with commission.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/methodology
Updated: 2026-10-28

The This GLP standard

# Methodology

We rank the companies selling GLP-1. Those rankings are worth something only if you can see how they are produced, so here is the whole thing: the scoring weights, the rules we hold ourselves to, and the one place commercial relationships are allowed to show up.

## How a score is calculated

Every provider score is a weighted average of 5 marks. There is no field anywhere in this site’s data where a score can be typed in by hand — a rank is an output of the table below, and nothing else.

-   ### Price transparency
    
    30%
    
    Can you find what a month costs — for the molecule and the form you want — before creating an account, and does the seller's own site agree with itself?
    
-   ### Honest headline
    
    10%
    
    Is the figure the seller leads with the figure it bills? A price that needs a twelve-month prepay, or that is struck through from an anchor nobody pays, is a different number from a standing monthly rate.
    
-   ### Dose-ladder pricing
    
    10%
    
    Does the price hold as your dose escalates, or is it re-set at every step? This is the difference most buyers only discover in month three.
    
-   ### State coverage
    
    25%
    
    How much of the country the seller actually ships to. A seller that does not operate where you live is not an option, whatever it charges.
    
-   ### Molecule and form breadth
    
    25%
    
    Whether the seller carries both molecules, and whether it offers an oral as well as an injection. Breadth is what lets you change course without changing provider.
    

The score broken into twenty units of 5 percent each: price transparency takes six, honest headline takes two, dose-ladder pricing takes two, state coverage takes five, molecule and form breadth takes five, filling all twenty with no unit left for anything commercial. · WHAT MAKES UP A SCORE · Price transparency · 30% · Honest headline · 10% · Dose-ladder pricing · 10% · State coverage · 25% · Molecule and form breadth · 25% · Each unit is 5% of the score. 20 units is the whole of it.

**The scoring function does not read commercial status.** It is not weighted low; it is not an input at all. Partners are shown first on category pages and labeled “Partner” — that is display order, and it never touches the number.

**31 of the 580 sellers we rank pay us a commission.** The seller our rubric places first, **Rivo Health**, is not one of them — we earn nothing when you click through to it. That is the check we would want to make of a site like this one, so we publish it rather than describe it. Partner status changes where a row sits on a board, and never the number beside it.

1.  01
    
    ## Primary sources, never summaries
    
    Every factual claim is tied to the trial publication, the FDA / DailyMed label, or the peer-reviewed paper of record. We do not cite press releases, secondary blogs, or AI-generated summaries as evidence.
    
2.  02
    
    ## Citations are live-verified
    
    Before publication, each reference is checked against the source of record — PubMed, DailyMed, ClinicalTrials.gov — to confirm the authors, year, journal, and the specific figure being cited. Citations are never reconstructed from memory.
    
3.  03
    
    ## Magnitude over vibes
    
    We report effect sizes, hazard ratios, confidence intervals, and durations — not adjectives. Where evidence is preclinical or thin, we say so plainly rather than implying more than the data supports.
    
4.  04
    
    ## Independence, disclosed
    
    This GLP earns revenue through clearly labeled partnerships with vetted telehealth and pharmacy providers. Those relationships are disclosed and never determine a ranking, a verdict, or a safety statement.
    
5.  05
    
    ## Research, not medical advice
    
    Our work is educational. It is not a substitute for an individualized consultation with a licensed clinician, and we say so on every page that discusses a medication or intervention.
    

## Frequently asked

What sources does This GLP cite?

Every factual claim is tied to a primary source — the trial publication, the FDA or DailyMed label, or the peer-reviewed paper of record. We do not treat press releases, secondary blogs, or AI-generated summaries as evidence.

How are citations verified?

Before publication, each reference is checked against the source of record — PubMed, DailyMed, or ClinicalTrials.gov — to confirm the authors, year, journal, and the specific figure being cited. Citations are never reconstructed from memory.

Do commercial partnerships affect your verdicts?

No. This GLP earns revenue through clearly labeled partnerships, but those relationships never determine a ranking, a verdict, or a safety statement. Placement can be commercial; the substance of the evidence review is not.

Is anything on This GLP medical advice?

No. Our work is educational research, not a substitute for individualized care from a licensed clinician. We say so on every page that discusses a medication or intervention.